Scott Epstein
@Avoro Capital Advisors Llc
Latest period2024 - Q3ReportedManaged Assets$6.858BTotal holdings36
Assets growth rate-8.66%Assets growth rate (2-Q avg)-10.54%Continuous growth in asset value0 quarters
Portfolio positions
This chart displays the top 10 holdings in Avoro Capital Advisors Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 36 positions.
Assets under management
The assets under management (AUM) of Avoro Capital Advisors Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 6.858B in assets, with a quarterly growth rate of -8.66% and a 2-quarter average growth rate of -10.54%. The portfolio is managed by Scott Epstein, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
CGONCg Oncology Inc
| 0.39% | $26.411M 700,000 shares@ $37.73 avg price | |
DYNDyne Therapeutics Inc.
| 0.35% | $23.348M 650,000 shares@ $35.92 avg price | Increased 461.56% |
SYRESpyre Therapeutics Inc
| 0.26% | $17.605M 598,600 shares@ $29.41 avg price | Decreased -67.45% |
AADIAadi Biosciences Inc
| 0.09% | $5.87M 2.849M shares@ $2.06 avg price | |
NGNENeurogene Inc
| 0.02% | $924,337 22,029 shares@ $41.97 avg price | |
4576⤦Insmed Inc
| 0.01% | $125,000↓ Put 50,000 shares@ $2.5 avg price | New Position |